Using R programming, marketers can create a marketing mix model to determine how sustainable their audience channels are, and make better ad spend decisions. Here's how

Bring some 'oomph' to your audience with these simple content hacks

The marketing industry has never had greater access to data than it does today. However, data alone does not drive your marketing organization. Decisions do. And with all the recent hype regarding the potential of AI, a successful cross-channel campaign is propelled by a personalized, data-driven approach injected with machine [...]

SAS Customer Intelligence 360: Hybrid marketing and analytic's last mile [Part 1] was published on Customer Intelligence Blog.

In part one of this blog series, we introduced hybrid marketing as a method that combines both direct and digital marketing capabilities while absorbing insights from machine learning. In part two, we will share perspectives on: How SAS Customer Intelligence 360 completes analytic's last mile. How campaign management processes can easily [...]

SAS Customer Intelligence 360: Hybrid marketing and analytic's last mile [Part 2] was published on Customer Intelligence Blog.

Your brand is customer journey obsessed, and every interaction with your company provides a potential opportunity to make an intelligent decision, deepen engagement and meet conversion goals. The hype of martech innovation in 2020 is continuing to elevate, and every technology vendor is claiming the following statement: "Bolster the customer [...]

SAS Customer Intelligence 360: Marketing AI vision was published on Customer Intelligence Blog.

In parts one and two of this blog series, we introduced hybrid marketing as a method that combines both direct and digital marketing capabilities while absorbing insights from machine learning. According to Daniel Newman (Futurum Research) and Wilson Raj (SAS) in the October 2019 research study Experience 2030: “Brands must [...]

SAS Customer Intelligence 360: Hybrid marketing and analytic's last mile [Part 3] was published on Customer Intelligence Blog.

Excitement levels are high for the March 2020 release of SAS Customer Intelligence 360, which includes multiple years of research and development culminating in enhancements to the platform's underlying data model. The changes will introduce the unification of a comprehensive data model recording both: Customer behavior -- what users are [...]

SAS Customer Intelligence 360: Unified data model, marketing attribution and AutoML was published on Customer Intelligence Blog.

After careful consideration of the evolving COVID-19 situation, SAS made the decision in March to cancel the in-person SAS Global Forum 2020 conference in Washington, DC. The health and well-being of SAS customers and employees was the company's top priority in making that decision, and while it's unfortunate that we [...]

SAS Global Forum 2020: Hybrid marketing with SAS Customer Intelligence 360 was published on Customer Intelligence Blog.

Direct selling, OTAs, loyalty. Travel intermediaries are having a strange impact on travel marketing.

Could packaging become part of the Internet of Things, delivering messages and even AR experiences to consumers?

Tips from executives on how to inspire creativity in the workplace

To fill your days with music between now and the Marketing Hall of Femme Summit & Awards on June 21, here's our HoF playlist

Join us on June 12 as we take an in-depth look at video marketing strategy

In the rapidly-growing video marketing space, it's essential to stay ahead of emerging trends

Philip Morris International became the world's leading tobacco brand by selling...well, cigarettes. Now it's planning on a smoke-free future

Tips from executives on how to inspire creativity in the workplace

To fill your days with music between now and the Marketing Hall of Femme Summit & Awards on June 21, here's our HoF playlist

Join us on June 12 as we take an in-depth look at video marketing strategy

In the rapidly-growing video marketing space, it's essential to stay ahead of emerging trends

Philip Morris International became the world's leading tobacco brand by selling...well, cigarettes. Now it's planning on a smoke-free future

India’s consumers have embraced online retail, creating a market worth A$52 billion that is expected to reach over A$100 billion by 2026. With a fast-growing ecommerce sector, India is creating major new market opportunities for Australian companies.

The Luxembourg regulator, the Commission de Surveillance du Secteur Financier (CSSF) has provided guidance on the meaning of marketing and reverse solicitation under AIFMD. This guidance is to be welcomed, as there is no European-wide guidance on th...

On 12 March 2018, the European Commission (the “Commission”) published legislative proposals for new rules on marketing AIFs and UCITS comprising: a Directive on the cross-border distribution of collective investment funds (COM(2018) 92...

During major sporting events, certain brands will actively pursue an “ambush marketing” strategy meaning that they will deliberately seek to associate their products with an event, despite not being one of the official sponsors. However,...

This speed read follows on from our briefing in November 2018 in which we explained that the government had proposed a change in law to implement a ban specific to pensions related cold calling.  At that time it was estimated that 10.9 million ...

Today’s companies see the importance of design as more consumers demand elegance alongside flawless functionality and exceptional user experience. As a company that has created countless ingenious product designs in different markets all over the ...

Background:

In 2015, Vyvanse (lisdexamfetamine) became the first Food and Drug Administration (FDA)-approved treatment for binge-eating disorder (BED), a condition first recognized by the DSM–V in 2013. Because pharmaceutical companies use continuing medical education (CME) to help sell drugs, we explored possible bias in CME modules on BED.

window.addEventListener("message", function (message) { var msg = message.data && JSON.parse(message.data); if (msg.name === "hapyak_embedded_experience_aspect_ratio_available") { var hyIframe = document.getElementById("hapyak_embedded_experience_6432"); hyIframe.style.paddingTop = 100 * (1 / […]

The post How to Measure Video Marketing Impact + KPIs for Every Team’s Video Program appeared first on e-Learning Feeds.

AstraZeneca LP and AstraZeneca Pharmaceuticals LP will pay $520 million to resolve allegations that AstraZeneca illegally marketed the anti-psychotic drug Seroquel for uses not approved as safe and effective by the Food and Drug Administration.

A Miami-area resident pleaded guilty today in U.S. District Court in Miami for her role in managing a community mental health care fraud scheme that resulted in the submission of more than $100 million in fraudulent claims to Medicare.

American pharmaceutical company Pfizer Inc. has agreed to pay $14.5 million to resolve False Claims Act allegations related to its marketing of the drug Detrol.

The United States has filed suit against Sonkei Communications Inc., and its principal corporate officers, Peter Turpel and Joseph Turpel.

Americall Group Inc. (AGI), a Naperville, Ill., telemarketing company specializing in sales for financial service and insurance companies, has agreed to settle charges that AGI violated “do not call” provisions of the Telemarketing Sales Rule.

Mississippi-based Cypress Pharmaceutical Inc., its subsidiary Hawthorn Pharmaceuticals Inc. and its CEO, Max Draughn, have agreed to pay $2.8 million to resolve civil allegations under the False Claims Act, the Justice Department announced today.

New Jersey-based Par Pharmaceutical Companies Inc. pleaded guilty in federal court today and agreed to pay $45 million to resolve its criminal and civil liability in the company’s promotion of its prescription drug Megace ES for uses not approved as safe and effective by the Food and Drug Administration and not covered by federal health care programs.

Wyeth Pharmaceuticals Inc., a pharmaceutical company acquired by Pfizer, Inc. in 2009, has agreed to pay $490.9 million to resolve its criminal and civil liability arising from the unlawful marketing of the prescription drug Rapamune for uses not approved as safe and effective by the U.S. Food and Drug Administration (FDA).

Pharmaceutical company Endo Health Solutions Inc. and its subsidiary Endo Pharmaceuticals Inc. (Endo) have agreed to pay $192.7 million to resolve criminal and civil liability arising from Endo’s marketing of the prescription drug Lidoderm for uses not approved as safe and effective by the Food and Drug Administration.

Pharmaceutical company Astellas Pharma US Inc. will pay $7.3 million to resolve allegations that it violated the False Claims Act in connection with its marketing and promotion of the drug Mycamine for pediatric use.